26.4 Environmental Heat Stroke & Severe Hypothermia

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

26.4 Environmental Heat Stroke & Severe Hypothermia

Key Takeaways Explain This Topic AI

Heat stroke is diagnosed by core body temperature >40°C (104°F) coupled with central nervous system dysfunction (delirium, ataxia, seizures, coma); intact mental status distinguishes heat exhaustion from heat stroke regardless of the absolute temperature.

Exertional heat stroke (strenuous exercise in athletes/military, profuse diaphoresis) requires immediate whole-body cold-water / ice-water immersion (cooling rate ~0.15-0.20°C/min); active cooling must be halted once core temperature reaches 38.3°C to 38.9°C (101-102°F) to prevent rebound hypothermia; antipyretics (acetaminophen, NSAIDs) are completely ineffective and exacerbate acute hepatic and renal injury.

Classic heat stroke occurs in elderly or chronically debilitated individuals during sustained environmental heat waves, exacerbated by anticholinergics, diuretics, and psychotropics, classically presenting with anhidrotic (dry) skin; first-line therapy utilizes evaporative and convective cooling (tepid water spray plus high-velocity fans).

Accidental hypothermia staging (Swiss Staging System: Stage I 32-35°C shivering/alert; Stage II 28-32°C shivering ceases/lethargic; Stage III 24-28°C unconscious/vital signs present; Stage IV <24°C cardiac arrest); characteristic electrocardiographic abnormalities include pathognomonic Osborn (J) waves, prolonged PR/QRS/QT intervals, severe bradycardia, and ventricular fibrillation.

In hypothermic cardiac arrest, resuscitation adheres to the rule 'Nobody is dead until warm and dead' (CPR continued until rewarmed to >32-35°C); patient handling must be exceptionally gentle to prevent triggering refractory ventricular fibrillation; severe cases require active internal rewarming (warmed IV crystalloids 42°C, heated humidified O2 42-46°C, cavity lavage, ECMO/cardiopulmonary bypass).

Last updated: September 2026

Environmental Hyperthermia: Heat Exhaustion vs. Heat Stroke

Thermoregulation maintains human core body temperature within a tightly regulated physiological range (36.5°C to 37.5°C [97.7°F to 99.5°F]) via hypothalamic coordination of cutaneous vasodilation and eccrine sweat evaporation. When environmental heat stress, excessive endogenous metabolic heat production, or impaired heat dissipation overwhelm these homeostatic mechanisms, progressive heat illness develops along a continuous clinical spectrum: heat cramps, heat exhaustion, and heat stroke.

The Defining Boundary: Heat Exhaustion vs. Heat Stroke

Heat Exhaustion :

Pathophysiology : Water and/or electrolyte depletion caused by prolonged environmental heat stress and strenuous exertion.

Clinical Presentation : Heavy sweating, headache, dizziness, nausea, vomiting, fatigue, muscle weakness, tachycardia, orthostatic hypotension, and syncope.

Core Temperature : Normal or moderately elevated, but strictly <40°C (<104°F) .

THE CARDINAL DIFFERENTIATOR : Central nervous system (CNS) function remains COMPLETELY INTACT . The patient is alert, oriented, and exhibits normal cognitive processing and cerebellar function.

Management : Move to a cool, shaded environment; remove restrictive clothing; place in supine position with legs elevated; provide oral rehydration with electrolyte solutions (or IV isotonic crystalloids if vomiting).

Heat Stroke :

Definition & Pathophysiology : A catastrophic, life-threatening medical emergency characterized by overwhelming hyperthermia causing systemic inflammatory response syndrome (SIRS), massive endothelial cell injury, microvascular thrombosis, and multi-organ dysfunction syndrome (MODS).

Diagnostic Dyad :

Core body temperature >40°C (>104°F) ; AND

Central Nervous System (CNS) dysfunction (delirium, agitation, ataxia, dysarthria, confusion, seizures, stupor, or coma).

Critical Diagnostic Rule : Core temperature MUST be confirmed via a continuous indwelling rectal thermistor probe or esophageal sensor. Oral, tympanic, temporal, and axillary thermometers are notoriously inaccurate in hyperthermic emergencies, frequently underestimating core temperature by 2°C to 3°C due to superficial skin cooling.

Exertional versus Classic (Non-Exertional) Heat Stroke

Heat stroke bifurcates into two distinct clinical and pathophysiological phenotypes: HEAT STROKE PHENOTYPE DIFFERENTIATION

• CLINICAL FEATURE EXERTIONAL HEAT STROKE CLASSIC (NON-EXERTIONAL)
• ─────────────────────────────────────────────────────────────────────────────
• Target Population Young, healthy athletes, Elderly, infants, poor, socially
• military recruits, laborers isolated, bedridden, infirm
• Precipitating Event Strenuous physical exertion Prolonged environmental heat wave
• in warm/humid environment without access to air conditioning
• Onset Speed Rapid (minutes to hours) Insidious (days of heat exposure)
• Cutaneous Exam Skin is PROFUSELY DIAPHORETIC Skin is ANHIDROTIC (hot, flushed,
• (wet, clammy) in >50% completely DRY; sweat glands exhausted)
• Medication Drivers Stimulants, creatine, ephedra Anticholinergics, phenothiazines,
• supplements, cocaine diuretics, TCAs, beta-blockers
• Rhabdomyolysis / AKI SEVERE; extreme CK surge, MILD to moderate; rhabdomyolysis
• acute tubular necrosis common is uncommon; mild renal azotemia
• Coagulopathy / DIC HIGH incidence; marked lysis, LOW to moderate incidence
• thrombocytopenia, petechiae
• Primary Cooling Method ICE-WATER IMMERSION EVAPORATIVE / CONVECTIVE COOLING
• (Rapid whole-body water bath) (Tepid water mist + large fans)
• Emergency Management of Heat Stroke & Critical Pharmacologic Pitfalls

Heat stroke is a medical emergency where cooling rate directly dictates survival : "Cool first, transport second." Mortality rises exponentially when core temperature remains elevated >40°C for longer than 30 minutes.

Guideline-Directed Rapid Cooling Modalities

Whole-Body Cold-Water / Ice-Water Immersion :

The Gold Standard for Exertional Heat Stroke .

Cooling Rate : Achieves the fastest known cooling velocity in clinical medicine: ~0.15°C to 0.20°C per minute (cooling the body by ~1°C every 5 to 7 minutes).

Execution : Submerge the patient up to the clavicles in a tub filled with ice-water slurry (1°C to 14°C [34°F to 57°F]). Continuously stir the water to break the thermal boundary layer around the body. Maintain continuous airway control and rectal temperature monitoring.

Evaporative and Convective Cooling :

The Preferred Method for Classic (Non-Exertional) Heat Stroke .

Rationale : Elderly, frail patients with classic heat stroke poorly tolerate cold-water immersion due to severe cardiovascular frailty, difficulty with continuous cardiopulmonary monitoring, and the risk of unmonitored aspiration.

Execution : Strip all clothing. Continuously spray the patient's entire skin surface with lukewarm / tepid water mist (20°C to 25°C) while positioning high-velocity fans directly over the body. Lukewarm water prevents peripheral cutaneous vasoconstriction and shivering, maximizing heat loss via evaporative convection.

THE MANDATORY COOLING ENDPOINT :

HALT ACTIVE RAPID COOLING ONCE CORE BODY TEMPERATURE REACHES 38.3°C to 38.9°C (101°F to 102°F) .

Critical Board Concept : The body's core temperature continues to decline for several minutes after removal from active cooling (the 'thermal inertia' or 'temperature drift'). Ceasing active cooling at 38.3°C to 38.9°C prevents catastrophic overshoot into unintended, life-threatening rebound hypothermia .

Pharmacologic Contraindications & Resuscitation Pearls

Antipyretics Are Strictly Contraindicated :

Acetaminophen, Aspirin, and NSAIDs HAVE ZERO ROLE IN HEAT STROKE AND ARE MEDICALLY CONTRAINDICATED .

Pathophysiology : In infectious fever, pyrogens stimulate hypothalamic prostaglandin E2 release, resetting the hypothalamic thermostat upward. In heat stroke, the hypothalamic set-point is entirely normal; hyperthermia results purely from physical heat accumulation overwhelming dissipation. Antipyretics are completely ineffective.

Toxic Harms : Acetaminophen drastically worsens impending acute hepatic necrosis (ischemic hepatitis / acute liver failure). Aspirin and NSAIDs worsen renal tubular injury, platelet dysfunction, and precipitate gastrointestinal bleeding in the setting of heat-induced coagulopathy and DIC.

Control of Shivering :

Shivering is an involuntary metabolic response that generates tremendous endogenous heat, counteracting therapeutic cooling. Administer short-acting intravenous benzodiazepines ( Lorazepam 1 to 2 mg IV or Diazepam) to abolish shivering and prevent agitation.

Aggressive Management of Multi-Organ Complications :

Rhabdomyolysis & Acute Kidney Injury : Infuse balanced IV crystalloids to maintain brisk urine output ( target UOP >200 to 300 mL/hr ). Monitor serum potassium, calcium, and creatine kinase closely.

Disseminated Intravascular Coagulation (DIC) : Monitor PT/INR, aPTT, fibrinogen, and D-dimer; replace blood products for active hemorrhage.

Accidental Hypothermia: Swiss Staging & Electrocardiographic Hallmarks

Accidental hypothermia is defined as an involuntary drop in core body temperature below 35°C (95°F) , typically occurring following immersion in cold water or prolonged exposure to cold ambient environments.

The Swiss Hypothermia Staging System

The Swiss Hypothermia Staging System provides a standardized, clinically actionable triage framework based on mental status, shivering thermogenesis, and vital signs: SWISS HYPOTHERMIA STAGING SYSTEM

• STAGE CORE TEMP CLINICAL MANIFESTATIONS RECOMMENDED THERAPY
• ─────────────────────────────────────────────────────────────────────────────
• Stage I 32°C - 35°C Conscious, alert, SHIVERING VIGOR- Passive external rewarming;
• (Mild) (89.6°F-95°F) OUSLY; tachycardia, tachypnea; Warm environment, warm sweet
• impaired fine motor coordination drinks; dry clothing
• ─────────────────────────────────────────────────────────────────────────────
• Stage II 28°C - 32°C Impaired consciousness, lethargy; Active external rewarming;
• (Mod) (82.4°F-89.6°F)SHIVERING CEASES; bradycardia, Forced-air warming blankets
• hypoventilation; dilated pupils (Bair Hugger) applied to trunk
• ─────────────────────────────────────────────────────────────────────────────
• Stage III 24°C - 28°C UNCONSCIOUS / COMATOSE; vital signs Active internal (core) rewarming;
• (Severe) (75.2°F-82.4°F)present but profound bradycardia & Warmed IV fluids (42°C), heated
• hypotension; extreme VF risk humidified O2, cavity lavage
• ─────────────────────────────────────────────────────────────────────────────
• Stage IV < 24°C APPARENT DEATH / CARDIAC ARREST; Full CPR + Active core rewarming;
• (Arrest) (< 75.2°F) Asystole or Ventricular Fib; Extracorporeal Life Support
• unresponsive, fixed pupils (ECMO / CPB); 'Warm & Dead'
• Electrocardiographic Manifestations of Hypothermia

As myocardial temperature drops, conduction velocity across all cardiac tissue slows, producing characteristic sequential ECG changes:

Osborn (J) Waves :

The Pathognomonic ECG Hallmark of Hypothermia .

Appearance : A distinct, dome-shaped or hump-like positive deflection occurring at the junction between the QRS complex and the ST segment ( the J-point ).

Distribution : Most prominent in the inferior leads (II, III, aVF) and lateral precordial leads (V4, V5, V6).

Correlation : The height and amplitude of the Osborn J wave correlate directly with the severity of hypothermia; the wave progressively diminishes and disappears as the patient is rewarmed.

Conduction Interval Prolongation : Progressive prolongation of the PR interval, QRS widening, and extreme QTc prolongation .

Arrhythmia Evolution :

Mild : Sinus tachycardia (early response to cold stress).

Moderate : Sinus bradycardia (physiologic slowing of sinus node pacemaker cells), progressing to atrial fibrillation with slow ventricular response below 32°C (benign; rarely requires antiarrhythmic treatment and converts spontaneously with rewarming).

Severe (<28°C) : Spontaneous Ventricular Fibrillation (VF) , extreme pulseless electrical activity (PEA), and asystole below 24°C.

• Advanced Resuscitation of Severe Hypothermia & Active Core Rewarming
• The Cardinal Resuscitation Dictum: 'Nobody Is Dead Until Warm and Dead'

Hypothermia exerts a profound neuroprotective effect by drastically depressing the cerebral metabolic rate for oxygen ( C M R O 2 CMRO_2 CMR O 2 ​ ). For every 1°C drop in core body temperature, cerebral metabolism declines by approximately 6% to 7% ; at 20°C, the brain can tolerate prolonged periods of circulatory arrest that would be fatal at normothermia.

Mandate : Cardiopulmonary resuscitation (CPR) must be initiated and continuously maintained during rewarming, even in patients who present with fixed, dilated pupils, absence of measurable pulse, and severe asystole.

Termination of Resuscitation : A hypothermic patient CANNOT be pronounced dead until active rewarming has restored the core body temperature to at least 32°C to 35°C (90°F to 95°F) without resumption of spontaneous circulation.

Exceptions to CPR : Obvious non-survivable physical trauma (e.g., decapitation, complete transection), a frozen rigid chest that physically prevents chest compressions, or a serum potassium >12 mmol/L (which denotes irreversible cellular lysis and tissue necrosis).

The 'Gentle Handling' Mandate

The hypothermic myocardium below 30°C (86°F) is extraordinarily irritable and prone to fatal arrhythmias.

Rough physical movement, vigorous jarring, chest percussion, or unnecessary endotracheal suctioning can instantaneously trigger refractory, irreversible Ventricular Fibrillation .

Management : Handle the patient with extreme gentleness. Keep the patient in a strictly horizontal, supine position. Cut off wet garments rather than manipulating limbs.

Active Rewarming Modalities

Rewarming strategies are selected based on the Swiss stage and clinical severity:

Passive External Rewarming : Remove wet clothing, cover with dry insulated blankets in a warm room (>24°C). Relies entirely on endogenous metabolic heat production (effective only in Stage I where shivering is intact).

Active External Rewarming : Application of exogenous heat to the body surface. Deploy forced-air warming blankets (e.g., Bair Hugger) or radiant warmers applied specifically to the trunk/core . Avoid active heating of the distal extremities: heating the limbs induces sudden peripheral vasodilation, shunting cold, acidotic blood from the extremities into the central circulation. This triggers 'core temperature afterdrop' and profound rewarming shock.

Active Internal (Core) Rewarming (Mandatory for Stage III and Stage IV) :

Intravenous Fluids : Infuse warmed isotonic crystalloids (normal saline or lactated Ringer's) heated to 40°C to 42°C (104°F to 107.6°F) .

Heated Humidified Oxygen : Administer warmed, humidified oxygen heated to 42°C to 46°C via face mask or endotracheal tube (delivers direct thermal energy to pulmonary capillaries and heart).

Body Cavity Lavage : In severe cases without ECMO access, perform closed-cavity lavage using sterile saline warmed to 40°C to 42°C:

• Bladder lavage via a 3-way triple-lumen Foley catheter;
• Gastric lavage via an NG tube;

Thoracic (pleural) lavage via two ipsilateral chest tubes (one anterior 2nd intercostal space for infusion, one posterior 5th intercostal space for drainage; provides direct warming to the mediastinum and pericardium).

Extracorporeal Life Support (ECLS / ECMO / Cardiopulmonary Bypass) :

The Gold Standard Treatment for Hypothermic Cardiac Arrest (Stage IV) and Refractory Shock .

Venoarterial (VA) ECMO or Cardiopulmonary Bypass (CPB) rewarms the core at 5°C to 10°C per hour while providing full systemic oxygenation and circulatory support, achieving survival rates exceeding 50% to 75% with intact neurological recovery.

Advanced Cardiac Life Support (ACLS) Modifications in Hypothermia

Standard ACLS resuscitation protocols require fundamental modifications below 30°C:

Defibrillation : If Ventricular Fibrillation or pulseless Ventricular Tachycardia is detected, attempt defibrillation ONCE at maximum energy (e.g., 200 J biphasic). If unsuccessful, defer further defibrillation attempts until the core temperature surpasses 30°C (86°F) . The cold myocardium is electrically refractory, and repeated shocks cause severe myocardial burn injury.

Resuscitation Medications (Epinephrine / Amiodarone) :

Core Temperature < 30°C : WITHHOLD ALL IV RESUSCITATION MEDICATIONS (epinephrine, vasopressin, amiodarone). Peripheral hepatic and renal clearance are halted; medications accumulate to massive toxic concentrations in the central circulation, producing lethal rebound arrhythmias and malignant hypertension upon rewarming.

Core Temperature 30°C to 35°C : Administer IV epinephrine, but double the dosing interval (e.g., administer every 6 to 10 minutes instead of the standard 3 to 5 minutes).

Core Temperature > 35°C : Resume standard ACLS dosing algorithms.

Loading diagram... Environmental Hyperthermia & Hypothermia Resuscitation Algorithm